Fair Value Calculator Fair Value Calculator
EN DE

8189 (8189) Fair Value & Analysis

Basic Materials · Market cap HK$294M

8 8189 8189 · HK
PriceHK$0.1380
Fair ValueHK$0.0800
Upside-42.0%
Quality33/100
Watch 8189 for free — get notified when fair value or trend changes. Watch for free
Evidence: Low

Fair value as of: Jul 2, 2026

From 1 valuation models · updated today

Share price −4.8% over the past month.

Price vs Fair Value (12 months)

HK$0.5200 HK$0.1220 Fair Value HK$0.0800 Jun 2025 Jul 2026

12‑month range HK$0.1220 – HK$0.5200 · the HK$0.1380 price screens above the HK$0.0800 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

8189 (8189) currently trades at HK$0.1380, while our model-based Fair Value estimate is HK$0.0800 — implying the stock looks roughly 42.0% overvalued today. We read business quality at 33/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 8189 generated revenue of HK$523M at a net margin of -17.4%. Revenue grew 7.0% year over year. Net debt stands at HK$80.6M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$523M
Revenue growth (YoY) +7.0%
Net margin -17.4%
Return on equity -729%
Free cash flow −HK$62.8M FY2025
Operating margin -20.6%
More key figures
EPS growth (YoY) +225%
Net debt HK$80.6M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

8189 reported revenue of HK$509M in FY2025 versus HK$476M in FY2021, a compound +1.7%/yr. Reported net income was −HK$88.5M in FY2025.

Revenue +1.7%/yr
FY21 HK$476M
FY22 HK$404M
FY23 HK$398M
FY24 HK$385M
FY25 HK$509M
Net income
FY21 −HK$42.3M
FY22 −HK$27.5M
FY23 −HK$20.2M
FY24 −HK$27.8M
FY25 −HK$88.5M

Is 8189 fairly valued? → Check now

Similar stocks

6 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Corteva, Inc CTVA $78.86 $41.93 -47%
Nutrien Ltd NTR $62.25 $80.29 +29%
Qinghai Salt Lake Industry Co 000792 ¥29.45 ¥21.15 -28%
CF Industries Holdings C1FI34 R$533.71 R$176.57 -67%
Yara International ASA YAR kr 469.90 kr 875.16 +86%
ICL Group ICL $5.50 $3.44 -37%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 8189 (8189) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.0800 versus a price of HK$0.1380 — about −42% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 8189?
Our model-based fair value for 8189 is HK$0.0800 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1380.
What is the quality score of 8189?
8189 has a Quality Score of 33/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 8189 (8189)?
8189 reported trailing-twelve-month revenue of about HK$523M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 8189?
The net profit margin of 8189 is about -17.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.